"sample_name"	"unique_patient_ID"	"alt_sample_name"	"sample_type"	"primarysite"	"summarygrade"	"G"	"summarystage"	"T"	"N"	"M"	"age_at_initial_pathologic_diagnosis"	"days_to_tumor_recurrence"	"recurrence_status"	"days_to_death"	"vital_status"	"os_binary"	"relapse_binary"	"family_history"	"msi"	"location"	"summarylocation"	"gender"	"kras"	"braf"	"line1"	"tumor_size"	"mss"	"mutation_apc"	"lymphnodesremoved"	"lymphnodesinvaded"	"stageall"	"ethnicity"	"dfs_status"	"days_to_recurrence_or_death"	"batch_1"	"batch_2"	"batch_3"	"drug_name"	"drug_treatment"	"drug_response"	"uncurated_author_metadata"
"GSM820048"	NA	"col001"	"tumor"	NA	NA	NA	NA	NA	NA	NA	42	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"2000"	NA	NA	NA	NA	NA	NA	"title: col001///geo_accession: GSM820048///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 41,6///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 2000///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL001.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820048/GSM820048.CEL.gz///data_row_count: 54675"
"GSM820049"	NA	"col002"	"tumor"	NA	NA	NA	NA	NA	NA	NA	66	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"140"	NA	NA	NA	NA	NA	NA	"title: col002///geo_accession: GSM820049///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 66,06///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 140///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL002.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820049/GSM820049.CEL.gz///data_row_count: 54675"
"GSM820050"	NA	"col003"	"tumor"	NA	NA	NA	NA	NA	NA	NA	80	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"62"	NA	NA	NA	NA	NA	NA	"title: col003///geo_accession: GSM820050///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 80,19///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 62///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL003.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820050/GSM820050.CEL.gz///data_row_count: 54675"
"GSM820051"	NA	"col004"	"tumor"	NA	NA	NA	NA	NA	NA	NA	87	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"832"	NA	NA	NA	NA	NA	NA	"title: col004///geo_accession: GSM820051///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 87,36///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: yes///characteristics_ch1.5: time to meta or recurrence: 832///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL004.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820051/GSM820051.CEL.gz///data_row_count: 54675"
"GSM820052"	NA	"col005"	"tumor"	NA	NA	NA	NA	NA	NA	NA	60	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1175"	NA	NA	NA	NA	NA	NA	"title: col005///geo_accession: GSM820052///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 60,49///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1175///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL005.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820052/GSM820052.CEL.gz///data_row_count: 54675"
"GSM820053"	NA	"col006"	"tumor"	NA	NA	NA	NA	NA	NA	NA	77	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1541"	NA	NA	NA	NA	NA	NA	"title: col006///geo_accession: GSM820053///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 76,55///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1541///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL006.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820053/GSM820053.CEL.gz///data_row_count: 54675"
"GSM820054"	NA	"col007"	"tumor"	NA	NA	NA	NA	NA	NA	NA	61	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1613"	NA	NA	NA	NA	NA	NA	"title: col007///geo_accession: GSM820054///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 61,3///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1613///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL007.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820054/GSM820054.CEL.gz///data_row_count: 54675"
"GSM820055"	NA	"col008"	"tumor"	NA	NA	NA	NA	NA	NA	NA	82	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"748"	NA	NA	NA	NA	NA	NA	"title: col008///geo_accession: GSM820055///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 82,16///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 748///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL008.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820055/GSM820055.CEL.gz///data_row_count: 54675"
"GSM820056"	NA	"col009"	"tumor"	NA	NA	NA	NA	NA	NA	NA	92	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1545"	NA	NA	NA	NA	NA	NA	"title: col009///geo_accession: GSM820056///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 92,15///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1545///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL009.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820056/GSM820056.CEL.gz///data_row_count: 54675"
"GSM820057"	NA	"col010"	"tumor"	NA	NA	NA	NA	NA	NA	NA	55	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1175"	NA	NA	NA	NA	NA	NA	"title: col010///geo_accession: GSM820057///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 54,56///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1175///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL010.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820057/GSM820057.CEL.gz///data_row_count: 54675"
"GSM820058"	NA	"col011"	"tumor"	NA	NA	NA	NA	NA	NA	NA	73	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"657"	NA	NA	NA	NA	NA	NA	"title: col011///geo_accession: GSM820058///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 73,41///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: yes///characteristics_ch1.5: time to meta or recurrence: 657///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL011.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820058/GSM820058.CEL.gz///data_row_count: 54675"
"GSM820059"	NA	"col012"	"tumor"	NA	NA	NA	NA	NA	NA	NA	55	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1137"	NA	NA	NA	NA	NA	NA	"title: col012///geo_accession: GSM820059///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 55,15///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1137///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL012.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820059/GSM820059.CEL.gz///data_row_count: 54675"
"GSM820060"	NA	"col013"	"tumor"	NA	NA	NA	NA	NA	NA	NA	83	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"499"	NA	NA	NA	NA	NA	NA	"title: col013///geo_accession: GSM820060///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 82,66///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 499///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL013.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820060/GSM820060.CEL.gz///data_row_count: 54675"
"GSM820061"	NA	"col014"	"tumor"	NA	NA	NA	NA	NA	NA	NA	84	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1470"	NA	NA	NA	NA	NA	NA	"title: col014///geo_accession: GSM820061///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 84,4///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1470///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL014.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820061/GSM820061.CEL.gz///data_row_count: 54675"
"GSM820062"	NA	"col015"	"tumor"	NA	NA	NA	NA	NA	NA	NA	50	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1433"	NA	NA	NA	NA	NA	NA	"title: col015///geo_accession: GSM820062///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 50,11///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1433///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL015.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820062/GSM820062.CEL.gz///data_row_count: 54675"
"GSM820063"	NA	"col016"	"tumor"	NA	NA	NA	NA	NA	NA	NA	48	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"2810"	NA	NA	NA	NA	NA	NA	"title: col016///geo_accession: GSM820063///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 47,7///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 2810///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL016.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820063/GSM820063.CEL.gz///data_row_count: 54675"
"GSM820064"	NA	"col017"	"tumor"	NA	NA	NA	NA	NA	NA	NA	65	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"2868"	NA	NA	NA	NA	NA	NA	"title: col017///geo_accession: GSM820064///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 64,9///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 2868///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL017.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820064/GSM820064.CEL.gz///data_row_count: 54675"
"GSM820065"	NA	"col018"	"tumor"	NA	NA	NA	NA	NA	NA	NA	75	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1774"	NA	NA	NA	NA	NA	NA	"title: col018///geo_accession: GSM820065///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 75,49///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1774///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL018.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820065/GSM820065.CEL.gz///data_row_count: 54675"
"GSM820066"	NA	"col019"	"tumor"	NA	NA	NA	NA	NA	NA	NA	76	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1928"	NA	NA	NA	NA	NA	NA	"title: col019///geo_accession: GSM820066///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 76,2///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1928///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL019.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820066/GSM820066.CEL.gz///data_row_count: 54675"
"GSM820067"	NA	"col020"	"tumor"	NA	NA	NA	NA	NA	NA	NA	66	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1060"	NA	NA	NA	NA	NA	NA	"title: col020///geo_accession: GSM820067///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 65,7///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: yes///characteristics_ch1.5: time to meta or recurrence: 1060///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL020.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820067/GSM820067.CEL.gz///data_row_count: 54675"
"GSM820068"	NA	"col021"	"tumor"	NA	NA	NA	NA	NA	NA	NA	86	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"929"	NA	NA	NA	NA	NA	NA	"title: col021///geo_accession: GSM820068///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 86,41///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 929///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL021.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820068/GSM820068.CEL.gz///data_row_count: 54675"
"GSM820069"	NA	"col022"	"tumor"	NA	NA	NA	NA	NA	NA	NA	48	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"3550"	NA	NA	NA	NA	NA	NA	"title: col022///geo_accession: GSM820069///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 48///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 3550///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL022.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820069/GSM820069.CEL.gz///data_row_count: 54675"
"GSM820070"	NA	"col023"	"tumor"	NA	NA	NA	NA	NA	NA	NA	42	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"2000"	NA	NA	NA	NA	NA	NA	"title: col023///geo_accession: GSM820070///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: col01///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1329///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL023.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820070/GSM820070.CEL.gz///data_row_count: 54675"
"GSM820071"	NA	"col024"	"tumor"	NA	NA	NA	NA	NA	NA	NA	76	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"204"	NA	NA	NA	NA	NA	NA	"title: col024///geo_accession: GSM820071///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 76,22///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: yes///characteristics_ch1.5: time to meta or recurrence: 204///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL024.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820071/GSM820071.CEL.gz///data_row_count: 54675"
"GSM820072"	NA	"col026"	"tumor"	NA	NA	NA	NA	NA	NA	NA	60	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"357"	NA	NA	NA	NA	NA	NA	"title: col026///geo_accession: GSM820072///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 60,11///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: yes///characteristics_ch1.5: time to meta or recurrence: 357///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL026.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820072/GSM820072.CEL.gz///data_row_count: 54675"
"GSM820073"	NA	"col033"	"tumor"	NA	NA	NA	NA	NA	NA	NA	82	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"994"	NA	NA	NA	NA	NA	NA	"title: col033///geo_accession: GSM820073///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 82,02///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 994///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL033.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820073/GSM820073.CEL.gz///data_row_count: 54675"
"GSM820074"	NA	"col034"	"tumor"	NA	NA	NA	NA	NA	NA	NA	79	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1413"	NA	NA	NA	NA	NA	NA	"title: col034///geo_accession: GSM820074///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 79,05///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1413///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL034.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820074/GSM820074.CEL.gz///data_row_count: 54675"
"GSM820075"	NA	"col035"	"tumor"	NA	NA	NA	NA	NA	NA	NA	67	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"2157"	NA	NA	NA	NA	NA	NA	"title: col035///geo_accession: GSM820075///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 67,1///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 2157///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL035.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820075/GSM820075.CEL.gz///data_row_count: 54675"
"GSM820076"	NA	"col036"	"tumor"	NA	NA	NA	NA	NA	NA	NA	72	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1977"	NA	NA	NA	NA	NA	NA	"title: col036///geo_accession: GSM820076///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 71,9///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1977///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL036.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820076/GSM820076.CEL.gz///data_row_count: 54675"
"GSM820077"	NA	"col037"	"tumor"	NA	NA	NA	NA	NA	NA	NA	65	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1807"	NA	NA	NA	NA	NA	NA	"title: col037///geo_accession: GSM820077///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 64,62///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1807///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL037.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820077/GSM820077.CEL.gz///data_row_count: 54675"
"GSM820078"	NA	"col038"	"tumor"	NA	NA	NA	NA	NA	NA	NA	95	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"446"	NA	NA	NA	NA	NA	NA	"title: col038///geo_accession: GSM820078///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 95,13///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 446///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL038.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820078/GSM820078.CEL.gz///data_row_count: 54675"
"GSM820079"	NA	"col039"	"tumor"	NA	NA	NA	NA	NA	NA	NA	72	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1859"	NA	NA	NA	NA	NA	NA	"title: col039///geo_accession: GSM820079///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 71,83///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1859///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL039.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820079/GSM820079.CEL.gz///data_row_count: 54675"
"GSM820080"	NA	"col040"	"tumor"	NA	NA	NA	NA	NA	NA	NA	77	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"2273"	NA	NA	NA	NA	NA	NA	"title: col040///geo_accession: GSM820080///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 76,79///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 2273///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL040.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820080/GSM820080.CEL.gz///data_row_count: 54675"
"GSM820081"	NA	"col041"	"tumor"	NA	NA	NA	NA	NA	NA	NA	58	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1959"	NA	NA	NA	NA	NA	NA	"title: col041///geo_accession: GSM820081///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 57,72///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1959///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL041.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820081/GSM820081.CEL.gz///data_row_count: 54675"
"GSM820082"	NA	"col044"	"tumor"	NA	NA	NA	NA	NA	NA	NA	78	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1278"	NA	NA	NA	NA	NA	NA	"title: col044///geo_accession: GSM820082///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 78,27///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: yes///characteristics_ch1.5: time to meta or recurrence: 1278///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL044.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820082/GSM820082.CEL.gz///data_row_count: 54675"
"GSM820083"	NA	"col045"	"tumor"	NA	NA	NA	NA	NA	NA	NA	75	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"269"	NA	NA	NA	NA	NA	NA	"title: col045///geo_accession: GSM820083///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 75,35///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: yes///characteristics_ch1.5: time to meta or recurrence: 269///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL045.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820083/GSM820083.CEL.gz///data_row_count: 54675"
"GSM820084"	NA	"col046"	"tumor"	NA	NA	NA	NA	NA	NA	NA	83	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"3555"	NA	NA	NA	NA	NA	NA	"title: col046///geo_accession: GSM820084///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 83,2///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 3555///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL046.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820084/GSM820084.CEL.gz///data_row_count: 54675"
"GSM820085"	NA	"col047"	"tumor"	NA	NA	NA	NA	NA	NA	NA	58	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"3599"	NA	NA	NA	NA	NA	NA	"title: col047///geo_accession: GSM820085///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 57,8///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 3599///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL047.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820085/GSM820085.CEL.gz///data_row_count: 54675"
"GSM820086"	NA	"col048"	"tumor"	NA	NA	NA	NA	NA	NA	NA	91	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"974"	NA	NA	NA	NA	NA	NA	"title: col048///geo_accession: GSM820086///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 90,57///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 974///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL048.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820086/GSM820086.CEL.gz///data_row_count: 54675"
"GSM820087"	NA	"col049"	"tumor"	NA	NA	NA	NA	NA	NA	NA	95	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1473"	NA	NA	NA	NA	NA	NA	"title: col049///geo_accession: GSM820087///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 94,56///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1473///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL049.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820087/GSM820087.CEL.gz///data_row_count: 54675"
"GSM820088"	NA	"col050"	"tumor"	NA	NA	NA	NA	NA	NA	NA	69	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"446"	NA	NA	NA	NA	NA	NA	"title: col050///geo_accession: GSM820088///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 68,57///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: yes///characteristics_ch1.5: time to meta or recurrence: 446///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL050.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820088/GSM820088.CEL.gz///data_row_count: 54675"
"GSM820089"	NA	"col051"	"tumor"	NA	NA	NA	NA	NA	NA	NA	76	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"236"	NA	NA	NA	NA	NA	NA	"title: col051///geo_accession: GSM820089///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 75,91///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 236///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL051.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820089/GSM820089.CEL.gz///data_row_count: 54675"
"GSM820090"	NA	"col052"	"tumor"	NA	NA	NA	NA	NA	NA	NA	57	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"332"	NA	NA	NA	NA	NA	NA	"title: col052///geo_accession: GSM820090///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 57,26///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: yes///characteristics_ch1.5: time to meta or recurrence: 332///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL052.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820090/GSM820090.CEL.gz///data_row_count: 54675"
"GSM820091"	NA	"col053"	"tumor"	NA	NA	NA	NA	NA	NA	NA	54	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"437"	NA	NA	NA	NA	NA	NA	"title: col053///geo_accession: GSM820091///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 54,07///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: yes///characteristics_ch1.5: time to meta or recurrence: 437///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL053.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820091/GSM820091.CEL.gz///data_row_count: 54675"
"GSM820092"	NA	"col054"	"tumor"	NA	NA	NA	NA	NA	NA	NA	51	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"438"	NA	NA	NA	NA	NA	NA	"title: col054///geo_accession: GSM820092///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 50,81///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: yes///characteristics_ch1.5: time to meta or recurrence: 438///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL054.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820092/GSM820092.CEL.gz///data_row_count: 54675"
"GSM820093"	NA	"col055"	"tumor"	NA	NA	NA	NA	NA	NA	NA	79	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1006"	NA	NA	NA	NA	NA	NA	"title: col055///geo_accession: GSM820093///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 78,78///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1006///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL055.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820093/GSM820093.CEL.gz///data_row_count: 54675"
"GSM820094"	NA	"col056"	"tumor"	NA	NA	NA	NA	NA	NA	NA	46	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"803"	NA	NA	NA	NA	NA	NA	"title: col056///geo_accession: GSM820094///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 46,44///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 803///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL056.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820094/GSM820094.CEL.gz///data_row_count: 54675"
"GSM820095"	NA	"col057"	"tumor"	NA	NA	NA	NA	NA	NA	NA	75	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"2414"	NA	NA	NA	NA	NA	NA	"title: col057///geo_accession: GSM820095///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 74,6///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 2414///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL057.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820095/GSM820095.CEL.gz///data_row_count: 54675"
"GSM820096"	NA	"col058"	"tumor"	NA	NA	NA	NA	NA	NA	NA	69	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1174"	NA	NA	NA	NA	NA	NA	"title: col058///geo_accession: GSM820096///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 68,91///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1174///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL058.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820096/GSM820096.CEL.gz///data_row_count: 54675"
"GSM820097"	NA	"col059"	"tumor"	NA	NA	NA	NA	NA	NA	NA	35	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"391"	NA	NA	NA	NA	NA	NA	"title: col059///geo_accession: GSM820097///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 34,64///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: yes///characteristics_ch1.5: time to meta or recurrence: 391///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL059.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820097/GSM820097.CEL.gz///data_row_count: 54675"
"GSM820098"	NA	"col060"	"tumor"	NA	NA	NA	NA	NA	NA	NA	79	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"3065"	NA	NA	NA	NA	NA	NA	"title: col060///geo_accession: GSM820098///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 79,3///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 3065///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL060.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820098/GSM820098.CEL.gz///data_row_count: 54675"
"GSM820099"	NA	"col061"	"tumor"	NA	NA	NA	NA	NA	NA	NA	78	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"474"	NA	NA	NA	NA	NA	NA	"title: col061///geo_accession: GSM820099///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 78,09///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 474///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL061.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820099/GSM820099.CEL.gz///data_row_count: 54675"
"GSM820100"	NA	"col062"	"tumor"	NA	NA	NA	NA	NA	NA	NA	80	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"457"	NA	NA	NA	NA	NA	NA	"title: col062///geo_accession: GSM820100///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 80,38///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 457///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL062.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820100/GSM820100.CEL.gz///data_row_count: 54675"
"GSM820101"	NA	"col063"	"tumor"	NA	NA	NA	NA	NA	NA	NA	81	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1260"	NA	NA	NA	NA	NA	NA	"title: col063///geo_accession: GSM820101///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 80,57///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1260///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL063.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820101/GSM820101.CEL.gz///data_row_count: 54675"
"GSM820102"	NA	"col064"	"tumor"	NA	NA	NA	NA	NA	NA	NA	77	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"54"	NA	NA	NA	NA	NA	NA	"title: col064///geo_accession: GSM820102///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 77,12///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 54///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL064.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820102/GSM820102.CEL.gz///data_row_count: 54675"
"GSM820103"	NA	"col065"	"tumor"	NA	NA	NA	NA	NA	NA	NA	64	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1983"	NA	NA	NA	NA	NA	NA	"title: col065///geo_accession: GSM820103///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 63,5///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1983///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL065.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820103/GSM820103.CEL.gz///data_row_count: 54675"
"GSM820104"	NA	"col066"	"tumor"	NA	NA	NA	NA	NA	NA	NA	78	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1667"	NA	NA	NA	NA	NA	NA	"title: col066///geo_accession: GSM820104///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 77,79///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1667///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL066.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820104/GSM820104.CEL.gz///data_row_count: 54675"
"GSM820105"	NA	"col067"	"tumor"	NA	NA	NA	NA	NA	NA	NA	57	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"2141"	NA	NA	NA	NA	NA	NA	"title: col067///geo_accession: GSM820105///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 57///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 2141///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL067.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820105/GSM820105.CEL.gz///data_row_count: 54675"
"GSM820106"	NA	"col068"	"tumor"	NA	NA	NA	NA	NA	NA	NA	74	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1281"	NA	NA	NA	NA	NA	NA	"title: col068///geo_accession: GSM820106///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 74,06///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1281///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL068.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820106/GSM820106.CEL.gz///data_row_count: 54675"
"GSM820107"	NA	"col069"	"tumor"	NA	NA	NA	NA	NA	NA	NA	55	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"409"	NA	NA	NA	NA	NA	NA	"title: col069///geo_accession: GSM820107///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 55,21///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: yes///characteristics_ch1.5: time to meta or recurrence: 409///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL069.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820107/GSM820107.CEL.gz///data_row_count: 54675"
"GSM820108"	NA	"col070"	"tumor"	NA	NA	NA	NA	NA	NA	NA	76	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"56"	NA	NA	NA	NA	NA	NA	"title: col070///geo_accession: GSM820108///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 75,72///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 56///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL070.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820108/GSM820108.CEL.gz///data_row_count: 54675"
"GSM820109"	NA	"col072"	"tumor"	NA	NA	NA	NA	NA	NA	NA	77	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1640"	NA	NA	NA	NA	NA	NA	"title: col072///geo_accession: GSM820109///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 77,35///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1640///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL072.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820109/GSM820109.CEL.gz///data_row_count: 54675"
"GSM820110"	NA	"col073"	"tumor"	NA	NA	NA	NA	NA	NA	NA	81	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"971"	NA	NA	NA	NA	NA	NA	"title: col073///geo_accession: GSM820110///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 80,75///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 971///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL073.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820110/GSM820110.CEL.gz///data_row_count: 54675"
"GSM820111"	NA	"col074"	"tumor"	NA	NA	NA	NA	NA	NA	NA	75	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1189"	NA	NA	NA	NA	NA	NA	"title: col074///geo_accession: GSM820111///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 74,72///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1189///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL074.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820111/GSM820111.CEL.gz///data_row_count: 54675"
"GSM820112"	NA	"col075"	"tumor"	NA	NA	NA	NA	NA	NA	NA	77	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1184"	NA	NA	NA	NA	NA	NA	"title: col075///geo_accession: GSM820112///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 76,57///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1184///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL075.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820112/GSM820112.CEL.gz///data_row_count: 54675"
"GSM820113"	NA	"col076"	"tumor"	NA	NA	NA	NA	NA	NA	NA	70	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1785"	NA	NA	NA	NA	NA	NA	"title: col076///geo_accession: GSM820113///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 69,53///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1785///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL076.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820113/GSM820113.CEL.gz///data_row_count: 54675"
"GSM820114"	NA	"col077"	"tumor"	NA	NA	NA	NA	NA	NA	NA	63	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1837"	NA	NA	NA	NA	NA	NA	"title: col077///geo_accession: GSM820114///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 63,07///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1837///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL077.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820114/GSM820114.CEL.gz///data_row_count: 54675"
"GSM820115"	NA	"col078"	"tumor"	NA	NA	NA	NA	NA	NA	NA	81	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1844"	NA	NA	NA	NA	NA	NA	"title: col078///geo_accession: GSM820115///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 81,41///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1844///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL078.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820115/GSM820115.CEL.gz///data_row_count: 54675"
"GSM820116"	NA	"col079"	"tumor"	NA	NA	NA	NA	NA	NA	NA	72	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"273"	NA	NA	NA	NA	NA	NA	"title: col079///geo_accession: GSM820116///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 72,46///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: yes///characteristics_ch1.5: time to meta or recurrence: 273///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL079.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820116/GSM820116.CEL.gz///data_row_count: 54675"
"GSM820117"	NA	"col080"	"tumor"	NA	NA	NA	NA	NA	NA	NA	64	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"538"	NA	NA	NA	NA	NA	NA	"title: col080///geo_accession: GSM820117///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 63,98///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: yes///characteristics_ch1.5: time to meta or recurrence: 538///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL080.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820117/GSM820117.CEL.gz///data_row_count: 54675"
"GSM820118"	NA	"col081"	"tumor"	NA	NA	NA	NA	NA	NA	NA	88	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1608"	NA	NA	NA	NA	NA	NA	"title: col081///geo_accession: GSM820118///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 88,03///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1608///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL081.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820118/GSM820118.CEL.gz///data_row_count: 54675"
"GSM820119"	NA	"col082"	"tumor"	NA	NA	NA	NA	NA	NA	NA	74	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"634"	NA	NA	NA	NA	NA	NA	"title: col082///geo_accession: GSM820119///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 73,98///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: yes///characteristics_ch1.5: time to meta or recurrence: 634///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL082.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820119/GSM820119.CEL.gz///data_row_count: 54675"
"GSM820120"	NA	"col083"	"tumor"	NA	NA	NA	NA	NA	NA	NA	76	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"736"	NA	NA	NA	NA	NA	NA	"title: col083///geo_accession: GSM820120///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 76,02///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 736///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL083.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820120/GSM820120.CEL.gz///data_row_count: 54675"
"GSM820121"	NA	"col084"	"tumor"	NA	NA	NA	NA	NA	NA	NA	67	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1378"	NA	NA	NA	NA	NA	NA	"title: col084///geo_accession: GSM820121///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 66,91///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1378///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL084.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820121/GSM820121.CEL.gz///data_row_count: 54675"
"GSM820122"	NA	"col085"	"tumor"	NA	NA	NA	NA	NA	NA	NA	54	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1582"	NA	NA	NA	NA	NA	NA	"title: col085///geo_accession: GSM820122///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 54,05///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1582///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL085.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820122/GSM820122.CEL.gz///data_row_count: 54675"
"GSM820123"	NA	"col086"	"tumor"	NA	NA	NA	NA	NA	NA	NA	64	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"447"	NA	NA	NA	NA	NA	NA	"title: col086///geo_accession: GSM820123///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 63,89///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: yes///characteristics_ch1.5: time to meta or recurrence: 447///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL086.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820123/GSM820123.CEL.gz///data_row_count: 54675"
"GSM820124"	NA	"col089"	"tumor"	NA	NA	NA	NA	NA	NA	NA	62	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1296"	NA	NA	NA	NA	NA	NA	"title: col089///geo_accession: GSM820124///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 61,5///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1296///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL089.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820124/GSM820124.CEL.gz///data_row_count: 54675"
"GSM820125"	NA	"col090"	"tumor"	NA	NA	NA	NA	NA	NA	NA	86	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"893"	NA	NA	NA	NA	NA	NA	"title: col090///geo_accession: GSM820125///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 86,06///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 893///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL090.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820125/GSM820125.CEL.gz///data_row_count: 54675"
"GSM820126"	NA	"col091"	"tumor"	NA	NA	NA	NA	NA	NA	NA	85	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1219"	NA	NA	NA	NA	NA	NA	"title: col091///geo_accession: GSM820126///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 84,57///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1219///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL091.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820126/GSM820126.CEL.gz///data_row_count: 54675"
"GSM820127"	NA	"col092"	"tumor"	NA	NA	NA	NA	NA	NA	NA	86	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"200"	NA	NA	NA	NA	NA	NA	"title: col092///geo_accession: GSM820127///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 85,98///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: yes///characteristics_ch1.5: time to meta or recurrence: 200///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL092.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820127/GSM820127.CEL.gz///data_row_count: 54675"
"GSM820128"	NA	"col093"	"tumor"	NA	NA	NA	NA	NA	NA	NA	71	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1319"	NA	NA	NA	NA	NA	NA	"title: col093///geo_accession: GSM820128///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 71,26///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1319///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL093.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820128/GSM820128.CEL.gz///data_row_count: 54675"
"GSM820129"	NA	"col094"	"tumor"	NA	NA	NA	NA	NA	NA	NA	87	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"344"	NA	NA	NA	NA	NA	NA	"title: col094///geo_accession: GSM820129///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 87,06///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 344///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL094.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820129/GSM820129.CEL.gz///data_row_count: 54675"
"GSM820130"	NA	"col095"	"tumor"	NA	NA	NA	NA	NA	NA	NA	52	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1230"	NA	NA	NA	NA	NA	NA	"title: col095///geo_accession: GSM820130///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 52,5///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1230///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL095.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820130/GSM820130.CEL.gz///data_row_count: 54675"
"GSM820131"	NA	"col096"	"tumor"	NA	NA	NA	NA	NA	NA	NA	62	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1147"	NA	NA	NA	NA	NA	NA	"title: col096///geo_accession: GSM820131///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 61,91///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1147///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL096.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820131/GSM820131.CEL.gz///data_row_count: 54675"
"GSM820132"	NA	"col097"	"tumor"	NA	NA	NA	NA	NA	NA	NA	62	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1042"	NA	NA	NA	NA	NA	NA	"title: col097///geo_accession: GSM820132///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 61,76///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1042///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL097.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820132/GSM820132.CEL.gz///data_row_count: 54675"
"GSM820133"	NA	"col098"	"tumor"	NA	NA	NA	NA	NA	NA	NA	49	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1094"	NA	NA	NA	NA	NA	NA	"title: col098///geo_accession: GSM820133///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 48,82///characteristics_ch1.3: Sex: m///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1094///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL098.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820133/GSM820133.CEL.gz///data_row_count: 54675"
"GSM820134"	NA	"col099"	"tumor"	NA	NA	NA	NA	NA	NA	NA	69	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1061"	NA	NA	NA	NA	NA	NA	"title: col099///geo_accession: GSM820134///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 68,84///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1061///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL099.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820134/GSM820134.CEL.gz///data_row_count: 54675"
"GSM820135"	NA	"col100"	"tumor"	NA	NA	NA	NA	NA	NA	NA	81	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"50"	NA	NA	NA	NA	NA	NA	"title: col100///geo_accession: GSM820135///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 81,42///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: na///characteristics_ch1.5: time to meta or recurrence: 50///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL100.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820135/GSM820135.CEL.gz///data_row_count: 54675"
"GSM820136"	NA	"col101"	"tumor"	NA	NA	NA	NA	NA	NA	NA	78	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1431"	NA	NA	NA	NA	NA	NA	"title: col101///geo_accession: GSM820136///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 77,76///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1431///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL101.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820136/GSM820136.CEL.gz///data_row_count: 54675"
"GSM820137"	NA	"col102"	"tumor"	NA	NA	NA	NA	NA	NA	NA	49	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1428"	NA	NA	NA	NA	NA	NA	"title: col102///geo_accession: GSM820137///status: Public on Nov 05 2011///submission_date: Oct 20 2011///last_update_date: Mar 18 2013///type: RNA///channel_count: 1///source_name_ch1: Primary tumor resection///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: primary tumor resection///characteristics_ch1.2: age at diagnosis: 49,23///characteristics_ch1.3: Sex: f///characteristics_ch1.4: meta or recurrence within 3 years: no///characteristics_ch1.5: time to meta or recurrence: 1428///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: COL102.CEL///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM820nnn/GSM820137/GSM820137.CEL.gz///data_row_count: 54675"
"GSM1100477"	NA	"Normal mucosa, sample 1"	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	50	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1433"	NA	NA	NA	NA	NA	NA	"title: Normal mucosa, sample 1///geo_accession: GSM1100477///status: Public on Mar 18 2013///submission_date: Mar 18 2013///last_update_date: Apr 08 2013///type: RNA///channel_count: 1///source_name_ch1: Normal colon mucosa///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: normal colon mucosa///characteristics_ch1.2: matching tumor sample: col015///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: col027///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1100nnn/GSM1100477/GSM1100477_COL_27.CEL.gz///data_row_count: 33777"
"GSM1100478"	NA	"Normal mucosa, sample 2"	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	77	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1541"	NA	NA	NA	NA	NA	NA	"title: Normal mucosa, sample 2///geo_accession: GSM1100478///status: Public on Mar 18 2013///submission_date: Mar 18 2013///last_update_date: Apr 08 2013///type: RNA///channel_count: 1///source_name_ch1: Normal colon mucosa///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: normal colon mucosa///characteristics_ch1.2: matching tumor sample: col006///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: col028///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1100nnn/GSM1100478/GSM1100478_COL_28.CEL.gz///data_row_count: 33777"
"GSM1100479"	NA	"Normal mucosa, sample 3"	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	""	NA	NA	NA	NA	NA	NA	"title: Normal mucosa, sample 3///geo_accession: GSM1100479///status: Public on Mar 18 2013///submission_date: Mar 18 2013///last_update_date: Apr 08 2013///type: RNA///channel_count: 1///source_name_ch1: Normal colon mucosa///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: normal colon mucosa///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: col029///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1100nnn/GSM1100479/GSM1100479_COL_29.CEL.gz///data_row_count: 33777"
"GSM1100480"	NA	"Normal mucosa, sample 4"	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	""	NA	NA	NA	NA	NA	NA	"title: Normal mucosa, sample 4///geo_accession: GSM1100480///status: Public on Mar 18 2013///submission_date: Mar 18 2013///last_update_date: Apr 08 2013///type: RNA///channel_count: 1///source_name_ch1: Normal colon mucosa///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: normal colon mucosa///characteristics_ch1.2: ///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: col030///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1100nnn/GSM1100480/GSM1100480_COL_30.CEL.gz///data_row_count: 33777"
"GSM1100481"	NA	"Normal mucosa, sample 5"	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	60	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"1175"	NA	NA	NA	NA	NA	NA	"title: Normal mucosa, sample 5///geo_accession: GSM1100481///status: Public on Mar 18 2013///submission_date: Mar 18 2013///last_update_date: Apr 08 2013///type: RNA///channel_count: 1///source_name_ch1: Normal colon mucosa///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: normal colon mucosa///characteristics_ch1.2: matching tumor sample: col004///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: col031///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1100nnn/GSM1100481/GSM1100481_COL_31.CEL.gz///data_row_count: 33777"
"GSM1100482"	NA	"Normal mucosa, sample 6"	"adjacentnormal"	NA	NA	NA	NA	NA	NA	NA	60	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	"357"	NA	NA	NA	NA	NA	NA	"title: Normal mucosa, sample 6///geo_accession: GSM1100482///status: Public on Mar 18 2013///submission_date: Mar 18 2013///last_update_date: Apr 08 2013///type: RNA///channel_count: 1///source_name_ch1: Normal colon mucosa///organism_ch1: Homo sapiens///characteristics_ch1: disease status: AJCC stage II CRC///characteristics_ch1.1: tissue: normal colon mucosa///characteristics_ch1.2: matching tumor sample: col026///characteristics_ch1.3: ///characteristics_ch1.4: ///characteristics_ch1.5: ///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using Trizol (Invitrogen) and purified with RNeasy (Qiagen) according to manufacturers protocol.///label_ch1: biotin///label_protocol_ch1: RNA sample integrity was checked on an Agilent 2100 Bioanalyzer (Agilent Technologies). 4 g of total RNA was used for cRNA synthesis and fragmented. Labeling was performed with One-Cycle cDNA synthesis Kit (Affymetrix) according to manufacturers protocol. Sample quality was checked on a Bioanalyzer prior and after fragmentation.///taxid_ch1: 9606///hyb_protocol: 10 g of labeled cRNA was hybridized to Affymetrix Human genome U133 Plus 2.0 arrays according to manufacturers protocol (Affymetrix).///scan_protocol: Arrays were scanned with a GeneChip Scanner 3000 (Affymetrix) according to manufacturers protocol///description: col032///data_processing: Expression data (cel files) were normalized with the MAS5.0 algorithm (target signal = 100) using GCOS software (Affymetrix)///platform_id: GPL570///contact_name: Rogier,,Versteeg///contact_email: r.versteeg@amc.uva.nl///contact_department: Department of Human Genetics///contact_institute: Academic Medical Centre, University of Amsterdam///contact_address: P.O. Box 22700///contact_city: Amsterdam///contact_zip.postal_code: 1100DE///contact_country: Netherlands///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1100nnn/GSM1100482/GSM1100482_COL_32.CEL.gz///data_row_count: 33777"
